Digraph
Organize the world
Digraph
Search
Everything
This topic
Blog
Recent
Everything
Sign in
Lefamulin
Lefamulin
Xenleta
XENLETA
BC-3781
Parent topics
Intravenous antibiotics
Nabriva
New and investigational antibiotics
Oral antibiotics
Pleuromutilin antibiotics
This topic
Recent activity
You must be
signed in
to add and move topics and links.
2019-08 FDA approves use of lefamulin to treat community-acquired pneumonia
Antibiotic-resistant Streptococcus pneumoniae
Lefamulin
2019 Was a Year for Advancements in Infectious Disease
https://www.pharmacytimes.com/publications/issue/2019/December2019/2019-was-a-year-for-advancements-in-infectious-disease
Lefamulin
Pretomanid
Changes in Therapy Recommendations in the 2019 ATS/IDSA Guidelines for Community-Acquired Pneumonia
https://www.contagionlive.com/news/changes-in-therapy-recommendations-in-the-2019-atsidsa-guidelines-for-communityacquired-pneumonia
Amoxicillin
Ceftaroline
Cefuroxime
Lefamulin
Omadacycline
Sulbactam
FDA approves new antibiotic to treat community-acquired bacterial pneumonia | FDA
https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-treat-community-acquired-bacterial-pneumonia
2019-08 FDA approves use of lefamulin to treat community-acquired pneumonia
Lefamulin
IDWeek 2019 News Network: Areas of Improvement for CAP Guidelines
https://www.contagionlive.com/insights/idweek-news-network-2019/idweek-2019-news-network-areas-of-improvement-for-cap-guidelines
Lefamulin
Omadacycline
King of Prussia firm gets first drug approval from FDA
https://www.inquirer.com/business/fda-drug-antibiotic-approval-new-class-lefamulin-20190819.html
Lefamulin
Lefamulin Could Be Vital in the Pneumonia Fight | Drug Topics
https://www.drugtopics.com/latest/lefamulin-could-be-vital-pneumonia-fight
Bacterial pneumonia
Lefamulin
Moxifloxacin
Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP) Nasdaq:NBRV
https://www.globenewswire.com/news-release/2019/08/19/1903735/0/en/Nabriva-Therapeutics-Receives-U-S-FDA-Approval-of-Xenleta-lefamulin-to-Treat-Community-Acquired-Bacteria-Pneumonia-CABP.html
2019-08 FDA approves use of lefamulin to treat community-acquired pneumonia
Lefamulin
Nabriva
Nabriva scores its first FDA nod with novel antibiotic Xenleta | FiercePharma
https://www.fiercepharma.com/marketing/nabriva-scores-fda-nod-for-novel-antibiotic-to-treat-bacterial-pneumonia
2019-08 FDA approves use of lefamulin to treat community-acquired pneumonia
Lefamulin
Nabriva
Nabriva’s XENLETA™ (lefamulin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP) Now Available in the U.S.
https://finance.yahoo.com/news/nabriva-xenleta-lefamulin-treatment-community-110000724.html
Lefamulin
Nabriva
One molecule’s journey from discovery to market
https://cen.acs.org/pharmaceuticals/drug-development/One-molecules-journey-discovery-market/98/i24
Lefamulin
Retapamulin
Stewardship / Resistance Scan for Jul 30, 2020 | CIDRAP
https://www.cidrap.umn.edu/news-perspective/2020/07/stewardship-resistance-scan-jul-30-2020
Covid-19 and antimicrobial resistance
Lefamulin